Ghost Tree Capital, LLC Cabaletta Bio, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $29,609 - $77,180	-4,101 Reduced 1.09%	370,899 $2.77 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $3.78 Million - $5.71 Million	225,000 Added 150.0%	375,000 $6.4 Million
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $1.83 Million - $3.5 Million	150,000 New	150,000 $3.41 Million
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $226,800 - $529,200	-135,000 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$3.36 - $14.64 $117,600 - $512,400	35,000 Added 35.0%	135,000 $512,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $700,000 - $1.25 Million	100,000 New	100,000 $1.22 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.